EKEmine Karabul

Emine Karabul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emine Karabul has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pulmonary Dysfunction Contributes to Nocturnal Hypoxemia Beyond Obstructive Sleep Apnea Severity in Primary Sjögren Syndrome

    by Emine Karabul, Erdal Mehmet Aksoy, Sermin Borekci, Serdar Ugurlu, Baran Balcan

    Background/Objectives: Pulmonary involvement is a common extraglandular manifestation of primary Sjögren syndrome (pSS) and may impair pulmonary gas exchange. Although obstructive sleep apnea (OSA) has been reported in pSS, the relationship between nocturnal hypoxemia and pulmonary dysfunction remains unclear. We investigated whether nocturnal oxygenation abnormalities in pSS are associated with pulmonary functional impairment beyond OSA severity. Methods: In this controlled cross-sectional study, 44 patients with pSS and 88 controls underwent overnight polysomnography. Pulmonary function testing, including diffusing capacity of the lung for carbon monoxide (DLCO), and thoracic computed tomography were available for all pSS patients. Associations between nocturnal hypoxemia parameters and pulmonary function indices were assessed using correlation analyses. Predictors of minimum nocturnal oxygen saturation were evaluated using multivariable linear regression adjusted for age, body mass index, and apnea–hypopnea index. Results: Sleep-disordered breathing severity and nocturnal oxygenation profiles were comparable between patients with pSS and controls, with the exception of a lower proportion of REM sleep in the pSS group. Within the pSS cohort, minimum nocturnal oxygen saturation correlated positively with DLCO, DLCO% predicted, DLCO/VA, and FVC% predicted. DLCO% predicted remained independently associated with minimum nocturnal oxygen saturation after adjustment for age, BMI, and AHI. However, this association was attenuated after additional adjustment for FVC, suggesting overlapping contributions of diffusion impairment and restrictive ventilatory dysfunction to nocturnal oxygenation. Conclusions: Although overall nocturnal oxygenation did not differ from that of matched controls, pulmonary functional impairment was associated with worse nocturnal oxygenation within the pSS cohort. These findings suggest that nocturnal hypoxemia in pSS reflects multiple interrelated aspects of pulmonary dysfunction rather than OSA severity alone. Assessment of pulmonary function, including both DLCO and FVC, may therefore provide clinically relevant information when evaluating nocturnal oxygenation abnormalities in patients with pSS.

  • Late Breaking Abstract - Pulmonary Dysfunction Contributes to Nocturnal Hypoxemia Beyond Obstructive Sleep Apnea Severity in Primary Sjögren Syndrome

    by EmİNE Karabul, Sermin Borekci, Serdal Ugurlu, Baran Balcan

    Background: Pulmonary involvement is frequent in primary Sjögren syndrome (pSS) and may impair gas exchange. While obstructive sleep apnea (OSA) has been reported in pSS, the relationship between nocturnal hypoxemia and pulmonary dysfunction remains unclear. We investigated whether nocturnal oxygenation abnormalities in pSS are associated with pulmonary function impairment beyond OSA severity. Methods: In this controlled cross-sectional study, 44 patients with pSS and 88 controls underwent overnight polysomnography. Pulmonary function testing, including diffusing capacity of the lung for carbon monoxide (DLCO), was available for all patients with pSS. Associations between nocturnal hypoxemia and pulmonary function parameters were assessed using correlation and multivariable linear regression analyses. Results: Sleep-disordered breathing severity and nocturnal oxygenation burden were comparable between pSS patients and controls. REM sleep percentage was lower in pSS (12.4 vs. 15.2, p=0.025). Among patients with pSS, minimum nocturnal oxygen saturation correlated with DLCO (r=0.578, p<0.001), DLCO% predicted (r=0.556, p<0.001), and FVC% predicted (r=0.405, p=0.006). The number of oxygen saturation drops below 90% was inversely correlated with DLCO (r=-0.576, p<0.001) and DLCO% predicted (r=-0.541, p<0.001). In multivariable analysis, DLCO% remained independently associated with minimum nocturnal oxygen saturation after adjustment for age, body mass index, and apnea–hypopnea index (β=0.088, 95% CI 0.032–0.144, p=0.003). Conclusion: Impaired pulmonary function was strongly associated with nocturnal hypoxemia in pSS. Reduced DLCO independently predicted lower nocturnal oxygen saturation beyond OSA severity, supporting the presence of a pulmonary-related nocturnal hypoxemia phenotype in pSS.

  • SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period

    by Ersan Atahan, Emine Karabul, Ruveyda Akcin, Buket Caliskaner Ozturk, Aysegul Gencer, Bekir Kocazeybek

    Objective Due to the coronavirus disease 2019 (COVID-19) pandemic, a significant increase has been observed in patients diagnosed with pulmonary embolism (PE) in our clinic. In addition to COVID-19-related PE, the increase in the number of patients with unprovoked or idiopathic PE was also noteworthy. Although it is not surprising that PE due to immobilization was observed in elderly patients and patients with comorbidities at risk for PE during the pandemic, it is important to investigate the increase in the number of unprovoked PE. Thus, we aimed to show that a previous COVID-19 infection may be a risk factor in these patients by examining the presence of severe acute respiratory syndrome-causing coronavirus (SARS-CoV-2) antibodies in patients diagnosed with unprovoked PE. Materials and methods The participants of the study consisted of 45 consecutive patients who were diagnosed with PE in our clinic, had no risk factors for PE, were considered unprovoked (idiopathic) PE, and had no history of COVID-19. SARS-CoV-2 antibody titers were measured in the serum samples of the patients for detecting immunity as a result of encountering COVID-19. Results Of the 45 patients diagnosed with PE, 24 (53.3%) patients were diagnosed with computed tomography pulmonary angiogram (CTPA), and 21 (46.7%) patients were diagnosed with perfusion single-photon emission computed tomography (Q-SPECT/CT). Immunity acquired after encountering COVID-19 was checked with the NCP kit, which revealed positive results in 9 (20%) patients. Conclusion It should be kept in mind that some of the patients diagnosed with idiopathic PE during the pandemic may have embolism due to asymptomatic COVID-19. In addition, it is now known that COVID-19 also creates a tendency toward thrombosis in asymptomatic patients.

  • The frequency of obstructive sleep apnea in patients with primary Sjogren’s syndrome

    by Emine Karabul, Sermin Borekci, Serdal Ugurlu, Benan Musellim

    Introduction There is a lack of information about the frequency of obstructive sleep apnea (OSA) in primary Sjogren’s syndrome (pSS). Using all-night polysomnography (PSG), this study aimed to investigate the frequency of OSA in pSS and the factors affecting the frequency of OSA in this condition. Methods Consecutive patients with pSS who presented to the Collagen Tissue Diseases follow-up polyclinic of the Department of Chest Diseases between 1 April 2019 and 31 December, 2020, were included in the study. Demographic characteristics, chronic diseases, smoking history in pack-years, anthropometric data, Epworth Sleepiness Scale score, pulmonary function test parameters, current thorax computed tomography findings, and PSG data were recorded. The control group was created by the retrospective screening of patients admitted to the sleep polyclinic and who underwent PSG but did not have pSS. Results OSA was detected in 37 (84%) of 44 patients with pSS who underwent PSG. Of 37 patients with OSA, 25 (68%) had moderate or severe OSA. Snoring and witnessed apneas, REM%, snoring index, and maximum apnea and maximum hypopnea duration were statistically significantly lower in the pSS group compared with the control group (p < 0.001, p = 0.003, p = 0.025, p = 0.001, p = 0.028, and p = 0.035, respectively). Conclusion The frequency of OSA in patients with pSS was 84%, with a decrease in REM%. Although a correlation between symptoms suggesting OSA and the presence of radiological lung involvement, spirometry, and DLCO values with OSA could not be demonstrated, physicians are recommended to be attentive for the presence of OSA in all patients with pSS and to investigate OSA using PSG.


  • Correction to: Investigation of perfusion defects by Q‑SPECT/CT in patients with mild‑to‑moderate course of COVID‑19 and low clinical probability for pulmonary embolism

    by Buket Caliskaner Ozturk, Ersan Atahan, Aysegul Gencer, Deniz Ongel Harbiyeli, Emine Karabul, Nejdiye Mazıcan, Kubra Nur Toplutas, Hazal Cansu Acar, Sait Sager, Bilun Gemicioglu, et al.


  • Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism

    by Buket Caliskaner Ozturk, Ersan Atahan, Aysegul Gencer, Deniz Ongel Harbiyeli, Emine Karabul, Nejdiye Mazıcan, Kubra Nur Toplutas, Hazal Cansu Acar, Sait Sager, Bilun Gemicioglu, et al.

    Objective Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. Methods All patients who underwent Q-SPECT/CT with suspicion of embolism were examined retrospectively. Only patients with low clinical probability and mild-to-moderate course of COVID-19 for PE were included in the study. The patients were evaluated comparatively as those with and without perfusion defects. Patients were divided into laboratory suspicion, clinical suspicion, or clinical and laboratory suspicion. Results In outpatients with mild-to-moderate COVID-19 with low clinical probability for PE, PD without CT abnormality was detected with a rate of 36.6% with Q-SPECT/CT performed for complaints of high d-dimer and/or dyspnea. None of the patients had PD at more proximal level than the segment level. PD with no concomitant CT abnormality was observed with a rate of 56.5% in patients with both clinical and laboratory suspicion. For d-dimer = 0.5 mg/dL cut-off sensitivity is 85%, for d-dimer = 1.5 mg/dL cut-off specificity 81%. Conclusion Thrombosis tendency is also present in outpatients with mild-to-moderate COVID-19, and these patients should also be offered anticoagulant prophylaxis during the COVID-19 period.